Abstract: A protein selected from the group consisting of Chrdl1, Fam3c, Fam3b and a fragment thereof, or a polynucleotide encoding therefor, for use in treating or reducing the risk of heart disease.
Type:
Grant
Filed:
August 16, 2022
Date of Patent:
October 22, 2024
Assignee:
International Centre for Genetic Engineering and Biotechnology (ICGEB)
Abstract: The present invention refers to the EMID2 protein or its EMI domain or a nucleic acid coding thereof for use for the treatment of a tumor or for the treatment or prevention of metastasis. Compositions, vectors and formulations for the administration of EMID2 or its EMI domain or a nucleic acid coding thereof for the above mentioned uses are also within the scope of the invention.
Type:
Application
Filed:
May 11, 2021
Publication date:
August 3, 2023
Applicants:
INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY - ICGEB, UNIVERSITA' DEGLI STUDI DI TRIESTE
Abstract: The present invention provides a new artemisinin-dipeptidyl vinyl based compound of Formula (I) or a pharmaceutically acceptable salt thereof and a process for the preparation thereof. The present invention further also provides a pharmaceutical composition comprising compounds of Formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent or excipient to treat malaria.
Type:
Grant
Filed:
April 16, 2019
Date of Patent:
June 21, 2022
Assignees:
Council of Scientific and Industrial Research, International Centre for Genetic Engineering and Biotechnology (ICGEB)
Abstract: The present invention provides a modified bacterial strain capable of fermenting both hexose and pentose sugars for production of bioalcohol wherein a promoter of pyruvate dehydrogenase operon (PDH) is replaced with a promoter of a gene that is expressed under anaerobic conditions. The present invention further provides a method of obtaining modified bacterial strain capable of fermenting both hexose and pentose sugar for production of bioalcohol. The present invention also provides a method of fermenting lignocellulosic biomass having hexose and pentose sugar using the modified bacteria for production of biomass.
Type:
Grant
Filed:
March 14, 2017
Date of Patent:
March 13, 2018
Assignees:
DEPARTMENT OF BIOTECHNOLOGY MINISTRY OF SCIENCE & TECHNOLOGY, INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (ICGEB)
Inventors:
Syed Shams Yazdani, Neha Munjal, Anu Jose Mattam
Abstract: The present invention provides a modified bacterial strain capable of fermenting both hexose and pentose sugars for production of bioalcohol wherein a promoter of pyruvate dehydrogenase operon (PDH) is replaced with a promoter of a gene that is expressed under anaerobic conditions. The present invention further provides a method of obtaining modified bacterial strain capable of fermenting both hexose and pentose sugar for production of bioalcohol. The present invention also provides a method of fermenting lignocellulosic biomass having hexose and pentose sugar using the modified bacteria for production of biomass.
Type:
Grant
Filed:
August 30, 2013
Date of Patent:
April 25, 2017
Assignees:
DEPARTMENT OF BIOTECHNOLOGY MINISTRY OF SCIENCE & TECHNOLOGY, INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (ICGEB)
Inventors:
Syed Shams Yazdani, Neha Munjal, Anu Jose Mattam